{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:14Z","timestamp":1791175994324,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Residual inflammation and dysregulated lipid metabolism are closely associated with the extent of severe multivessel coronary disease (MVD) in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The fibrinogen-to-platelet ratio (FPR) and the apolipoprotein B\/apolipoprotein A1 (ApoB\/ApoA1) ratio reflect these two residual risk pathways, respectively, whereas the clinical value of their combined assessment for pre-angiographic identification of severe MVD remains to be evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the incremental value of combining FPR with the ApoB\/ApoA1 ratio for pre-angiographic identification of severe MVD in patients with NSTEMI and to develop an adjunctive risk-stratification model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study included 580 patients with NSTEMI who underwent coronary angiography. Correlation analyses, logistic regression, and restricted cubic spline models were used to assess the associations between the two biomarkers and MVD. The area under the receiver operating characteristic curve (AUC), continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate the incremental value of the biomarkers. A nomogram was developed and internally validated using bootstrap resampling. Decision curve analysis (DCA) was performed to assess net clinical benefit, and subgroup analyses were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FPR remained independently and positively associated with severe MVD, with an approximately linear dose-response relationship; the association of the ApoB\/ApoA1 ratio was attenuated after full adjustment, although it showed complementary value in patients with a very high coronary lesion burden. With the combined model, the AUC increased from 0.683 to 0.719, while the continuous NRI and IDI were 0.488 and 0.037, respectively; adding the ApoB\/ApoA1 ratio to the model containing FPR did not significantly improve the AUC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.266) but yielded further improvements in NRI and IDI. Potential effect modification by diabetes status was observed (\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u2009=\u20090.025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FPR is an important adjunctive biomarker for the pre-angiographic identification of severe MVD in patients with NSTEMI, whereas the ApoB\/ApoA1 ratio provides complementary reclassification information. The nomogram incorporating both biomarkers may facilitate pre-angiographic risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1931950","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:35:51Z","timestamp":1791174951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined assessment of fibrinogen-to-platelet ratio and ApoB\/ApoA1 ratio for pre-angiographic risk stratification of severe multivessel coronary disease in NSTEMI"],"prefix":"10.3389","volume":"13","author":[{"given":"Zongqi","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of General Practice, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of General Practice, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Practice, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Practice, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Statistics, Columbia University","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Practice, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1399","DOI":"10.4244\/EIJ-D-25-00100","article-title":"Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndrome","volume":"21","author":"Kovacevic","year":"2025","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/eurheartj\/ehaf958","article-title":"Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management","volume":"47","author":"Savonitto","year":"2026","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2025.04.007","article-title":"Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease - design and rationale of the randomized COMPLETE-NSTEMI trial","volume":"287","author":"Feistritzer","year":"2025","journal-title":"Am Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jacasi.2026.01.029","article-title":"Comparison of clinical outcomes between incomplete and complete revascularization in NSTEMI patients with multivessel disease","volume":"6","author":"Kim","year":"2026","journal-title":"JACC Asia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehae700","article-title":"Percutaneous vs. Surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry","volume":"46","author":"Omerovic","year":"2024","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1614843","DOI":"10.3389\/fcvm.2025.1614843","article-title":"Revascularization strategies in non-ST segment elevation myocardial infarction: the clash continues","volume":"12","author":"Zuccarelli","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jcin.2024.01.278","article-title":"Timing of complete multivessel revascularization in patients presenting with non-ST-segment elevation acute coronary syndrome","volume":"17","author":"Elscot","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.123.067938","article-title":"Comparison of incidence and prognostic impact of ischemic, major bleeding and heart failure events in patients with chronic coronary syndrome: insights from the CORONOR registry","volume":"149","author":"Lemesle","year":"2024","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12944-024-02156-3","article-title":"The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention","volume":"23","author":"Liao","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e45483","DOI":"10.7759\/cureus.45483","article-title":"Inflammation in cardiovascular disease: a comprehensive review of biomarkers and therapeutic targets","volume":"15","author":"Gupta","year":"2023","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MOL.0000000000000779","article-title":"The iterative lipid impact on inflammation in atherosclerosis","volume":"32","author":"Kraaijenhof","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/09603123.2025.2557428","article-title":"The assessment of the fibrinogen-to-platelet ratio for predicting mortality of COVID-19 in non-diabetic subjects","volume":"36","author":"Reyes-Ruiz","year":"2026","journal-title":"Int J Environ Health Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00392-025-02767-5","article-title":"Association of apolipoprotein B, excess apolipoprotein B and apoB\/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002\u20132022)","volume":"115","author":"Giannakopoulou","year":"2026","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1016\/j.jacl.2024.08.013","article-title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the national lipid association","volume":"18","author":"Soffer","year":"2024","journal-title":"J Clin Lipidol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12872-021-02400-z","article-title":"Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome","volume":"21","author":"Duan","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12937-025-01078-9","article-title":"Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China","volume":"24","author":"Ye","year":"2025","journal-title":"Nutr J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e073843","DOI":"10.1136\/bmj-2022-073843","article-title":"Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial","volume":"381","author":"Gale","year":"2023","journal-title":"The BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41598-025-30804-w","article-title":"Real-world study to compare functional SYNTAX score versus anatomical SYNTAX score in influencing the treatment strategy for multivessel disease patients","volume":"16","author":"Wongpraparut","year":"2025","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","article-title":"Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review","volume":"22","author":"Binuya","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","article-title":"Descriptive statistics and normality tests for statistical data","volume":"22","author":"Mishra","year":"2019","journal-title":"Ann Card Anaesth"},{"key":"B27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/sur.2020.430","article-title":"Basic introduction to statistics in medicine, part 2: comparing data","volume":"22","author":"Bensken","year":"2021","journal-title":"Surg Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","article-title":"Statistical notes for clinical researchers: chi-squared test and fisher\u2019s exact test","volume":"42","author":"Kim","year":"2017","journal-title":"Restor Dent Endod"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cjca.2020.11.010","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/cc2857","article-title":"Statistics review 10: further nonparametric methods","volume":"8","author":"Bewick","year":"2004","journal-title":"Crit Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1213\/ANE.0000000000005247","article-title":"Logistic regression in medical research","volume":"132","author":"Schober","year":"2021","journal-title":"Anesth Analg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4172\/2161-1165.1000227","article-title":"Multicollinearity in regression analyses conducted in epidemiologic studies","volume":"6","author":"Vatcheva","year":"2016","journal-title":"Epidemiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"B35","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Casp J Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/sim.4348","article-title":"Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models","volume":"31","author":"Pencina","year":"2012","journal-title":"Stat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e2455368","DOI":"10.1001\/jamanetworkopen.2024.55368","article-title":"Genomic drivers of coronary artery disease and risk of future outcomes after coronary angiography","volume":"8","author":"Supriami","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users\u2019 guide to the medical literature","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","year":"2025","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/eurjpc\/zwaf112","article-title":"Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease","volume":"33","author":"Di Muro","year":"2026","journal-title":"Eur J Prev Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/biom11071036","article-title":"Fibrinogen and a triad of thrombosis, inflammation, and the renin-angiotensin system in premature coronary artery disease in women: a new insight into sex-related differences in the pathogenesis of the disease","volume":"11","author":"Kryczka","year":"2021","journal-title":"Biomolecules"},{"key":"B44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/ijms23010193","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases-review of the literature and clinical studies","volume":"23","author":"Surma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1055\/s-0044-1795097","article-title":"The role of platelets in atherosclerosis: a historical review","volume":"51","author":"Momi","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"B46","doi-asserted-by":"publisher","first-page":"823549","DOI":"10.3389\/fcvm.2022.823549","article-title":"Platelet subtypes in inflammatory settings","volume":"9","author":"Hamad","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.3390\/jcm15082926","article-title":"Fibrinogen-to-platelet ratio and hematologic inflammatory indexes in spondylarthritis","volume":"15","author":"Ungureanu","year":"2026","journal-title":"J Clin Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41569-024-01111-0","article-title":"Apolipoprotein B-containing lipoproteins in atherogenesis","volume":"22","author":"Bor\u00e9n","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4610834","DOI":"10.1155\/2022\/4610834","article-title":"Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives","volume":"2022","author":"Xu","year":"2022","journal-title":"Cardiovasc Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1417270","DOI":"10.3389\/fimmu.2024.1417270","article-title":"Anti-inflammatory mechanism of apolipoprotein A-I","volume":"15","author":"Tao","year":"2024","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-021-01381-9","article-title":"Association between apolipoprotein B\/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study","volume":"20","author":"Deng","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"925923","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/14779072.2025.2543537","article-title":"High apoB\/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines","volume":"23","author":"Walldius","year":"2025","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8959019","DOI":"10.1155\/2021\/8959019","article-title":"Apolipoprotein B\/A1 ratio is associated with severity of coronary artery stenosis in CAD patients but not in non-CAD patients undergoing percutaneous coronary intervention","volume":"2021","author":"Hua","year":"2021","journal-title":"Dis Markers"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1161\/ATVBAHA.123.320330","article-title":"Spatial transcriptomic approach to understanding coronary atherosclerotic plaque stability","volume":"44","author":"Gastanadui","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41598-024-84092-x","article-title":"Apob\/ApoA-\u0399 is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/ehjdh\/ztae071","article-title":"Validation of machine learning-based risk stratification scores for patients with acute coronary syndrome treated with percutaneous coronary intervention","volume":"5","author":"Molenaar","year":"2024","journal-title":"Eur Heart J Digit Health"},{"key":"B59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jacasi.2026.01.002","article-title":"Cholesterol-inflammation fusion hypothesis in atherosclerosis: an evolving paradigm in pathogenesis and therapy","volume":"6","author":"Zeng","year":"2026","journal-title":"JACC Asia"},{"key":"B60","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/antiox13050583","article-title":"Radical oxygen species, oxidized low-density lipoproteins, and lectin-like oxidized low-density lipoprotein receptor 1: a vicious circle in atherosclerotic process","volume":"13","author":"Munno","year":"2024","journal-title":"Antioxidants"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1485801","DOI":"10.3389\/fimmu.2025.1485801","article-title":"Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins","volume":"16","author":"Araujo","year":"2025","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"11386","DOI":"10.3390\/ijms252111386","article-title":"Oxidized low-density lipoprotein and its role in immunometabolism","volume":"25","author":"Mosalmanzadeh","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1430293","DOI":"10.3389\/fphar.2024.1430293","article-title":"The relationship of redox signaling with the risk for atherosclerosis","volume":"15","author":"Lei","year":"2024","journal-title":"Front Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/antiox15010055","article-title":"Phagocyte NADPH oxidase NOX2-derived reactive oxygen species in antimicrobial defense: mechanisms, regulation, and therapeutic potential-A","volume":"15","author":"\u021aocu","year":"2025","journal-title":"Narrative Review. Antioxidants"},{"key":"B65","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00415-023-12003-7","article-title":"Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease","volume":"271","author":"Kerner","year":"2024","journal-title":"J Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/JIR.S504673","article-title":"Platelet factor 4: a mysterious chemokine in inflammatory regulation diseases","volume":"18","author":"Ji","year":"2025","journal-title":"J Inflamm Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.13794","article-title":"Platelets as an inter-player between hyperlipidaemia and atherosclerosis","volume":"296","author":"Li","year":"2024","journal-title":"J Intern Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","article-title":"Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction","volume":"21","author":"Xue","year":"2023","journal-title":"Cell Commun Signal CCS"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging-guided or angiography-guided complex PCI","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.amjcard.2024.04.003","article-title":"Acute coronary syndrome revascularization strategies with multivessel coronary artery disease","volume":"220","author":"Widmer","year":"2024","journal-title":"Am J Cardiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1093\/eurheartj\/ehad369","article-title":"PCI or CABG for left main coronary artery disease: the SWEDEHEART registry","volume":"44","author":"Persson","year":"2023","journal-title":"Eur Heart J"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1931950\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:35:57Z","timestamp":1791174957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1931950\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":73,"alternative-id":["10.3389\/fcvm.2026.1931950"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1931950","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1931950"}}